此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Resuscitation Outcomes in the Netherlands (ROUTiNE)

2019年7月14日 更新者:Marc Schluep、Erasmus Medical Center

Resuscitation Outcomes in the Netherlands Study

The Resuscitation Outcomes in the Netherlands - study assesses one-year survival and quality of life after In-Hospital Cardiac Arrest(IHCA). It's design is a multicenter prospective observational cohort study which will include all patients undergoing cardiopulmonary resuscitation (CPR) for IHCA in 2017. Current literature describes poor survival after IHCA and no risk stratification tool for long-term outcome is available. Furthermore no such study has ever been performed in the Netherlands. The investigators aim to gain further insight in this major adverse event.

研究概览

详细说明

Background: In-hospital cardiac arrest (IHCA) is a serious adverse event for which cardiopulmonary resuscitation (CPR) can be performed to restore circulation. Currently survival after IHCA is poor. To assess the success of resuscitation attempts there is a need for research that focuses on long-term survival and quality of life. Patient selection for CPR, prevention of cardiac arrest and improvement of CPR techniques are crucial for improving qualitative survival. To assess the feasibility of this project a single-center retrospective cohort study was conducted over a 10-year period in the OLVG hospital. For all patients who received CPR survival to discharge was 32% and one-year survival was 22%. This is slightly higher than survival reported in contemporary literature. Due to it's design no prognostic variables could be derived from this study, however data suggested age and Charlson Comorbidity Index could prove useful in predicting long-term outcome. In the consecutive year this study was designed.

Hypothesis: The hypothesis is that one-year survival after IHCA in Dutch hospitals is poor, consistent with international literature and our feasibility trial, and survival can be improved through selection, prevention and training.

Objective: The main objective of this study is to assess the one-year survival of patients after CPR for in-hospital cardiac arrest. The secondary objectives are to assess quality of life and functional status after successful CPR. Furthermore the investigators aim to assess if there are patient-related predicting factors for these outcome measures and to assess whether outcomes are influenced by hospital-related factors (i.e. CPR training and treatment options).

Study design: The current study has a prospective, observational design, with a 12-month follow-up. Patients will be included from January 1st 2017. Patient data collection will take place at four time points: T0= directly post-CPR, T1= at hospital discharge or at in-hospital death, T2= 3 months after CPR, T3= 12 months after CPR. Clinical data will be collected at all time points. Quality of life data will be collected at T2 and T3 by means of validated questionnaires. We will assess functional status through questionnaires and link these to pre-existing and acquired comorbidities (e.g. stroke). General hospital data and data concerning the level of CPR-training will be ascertained at four moments during the first year of patient inclusion.

Study population: An estimated six hundred patients of 18 years or older who will receive CPR for cardiac arrest in the participating hospitals. This will include all cases of in-hospital cardiac arrest, also including Operation Room (OR), Intensive/Coronary Care Unit (ICU/CCU) and Emergency Department (ER). Patients in whom CPR was started before arrival in hospital will be excluded.

Expected results: The main study endpoints are one-year survival and quality of life. Secondary endpoints are direct survival and survival to discharge. The first preliminary results are expected in the first quarter of 2018. After conclusion of this project the investigators of this project aim to develop recommendations that will improve survival after IHCA.

研究类型

观察性的

注册 (实际的)

700

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Gelderland
      • Arnhem、Gelderland、荷兰、6815AD
        • Rijnstate Ziekenhuis
    • Noord-Holland
      • Amsterdam、Noord-Holland、荷兰、1091AC
        • OLVG
    • Overijssel
      • Deventer、Overijssel、荷兰、7416SE
        • Deventer Ziekenhuis
      • Enschede、Overijssel、荷兰、7512KZ
        • Medisch Spectrum Twente
      • Zwolle、Overijssel、荷兰、8025AB
        • Isala Klinieken
    • Zeeland
      • Terneuzen、Zeeland、荷兰、4535PA
        • Zorgsaam Zeeuws-Vlaanderen
    • Zuid-Holland
      • Breda、Zuid-Holland、荷兰、4818CK
        • Amphia Ziekenhuis
      • Delft、Zuid-Holland、荷兰、2625AD
        • Reinier de Graaf Gasthuis
      • Dordrecht、Zuid-Holland、荷兰、3318AT
        • Albert Schweitzer Ziekenhuis
      • Rotterdam、Zuid-Holland、荷兰、3079DZ
        • Maasstad Ziekenhuis
      • Rotterdam、Zuid-Holland、荷兰、3045PM
        • Sint Franciscus Vlietland Groep
      • The Hague、Zuid-Holland、荷兰
        • Haaglanden Medisch Centrum

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

取样方法

非概率样本

研究人群

An estimated six hundred patients of 18 years or older who will receive CPR for cardiac arrest in the participating hospitals (n=15). This will include all cases of in-hospital cardiac arrest, also including Operation Room (OR), Intensive/Coronary Care Unit (ICU/CCU) and Emergency Department (ER). Patients in whom CPR was started before arrival in hospital will be excluded.

描述

Inclusion Criteria:

  • Patients over 18 years of age
  • Receiving cardiopulmonary resuscitation, as defined by starting manual chest compressions, for a circulatory arrest occuring in-hospital.
  • In hospital is defined as all hospital wards, departments, outpatient clinics, and hallways.

Exclusion Criteria:

  • Children (<18 years of age)
  • Purposely induced cardiac arrest (e.g. cardiac surgery)
  • Purposely induced arrhythmias (e.g. electrophysiological treatment)
  • Refusal to participate
  • Primary out-of-hospital cardiac arrest with re-arrest <24h after hospital admission.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
one-year survival
大体时间:one year
Survival one year after in-hospital cardiac arrest
one year

次要结果测量

结果测量
措施说明
大体时间
SF-12
大体时间:3 months and one year after in-hospital cardiac arrest
Quality of life measured by SF-12 questionnaire
3 months and one year after in-hospital cardiac arrest
EuroQoL
大体时间:3 months and one year after in-hospital cardiac arrest
Quality of life measured by EuroQoL questionnaire
3 months and one year after in-hospital cardiac arrest
HADS
大体时间:3 months and one year after in-hospital cardiac arrest
Quality of life measured by Hospital Anxiety and Depression Scale questionnaire
3 months and one year after in-hospital cardiac arrest
Charlson Comorbidity Index
大体时间:3 months and one year after in-hospital cardiac arrest
Development of new comorbidities as defined by the Charlson Comorbidity Index.
3 months and one year after in-hospital cardiac arrest
Cardiovascular events
大体时间:3 months and one year after in-hospital cardiac arrest
Development of new cardiovascular events (e.g. myocardial infarction, stroke), by means of checkbox question.
3 months and one year after in-hospital cardiac arrest
Working life
大体时间:Prior to in-hospital cardiac arrest and 3 months and one year after in-hospital cardiac arrest
Participation in working life; status before cardiac arrest and after by means of checkbox question.
Prior to in-hospital cardiac arrest and 3 months and one year after in-hospital cardiac arrest
TICS
大体时间:3 months after in-hospital cardiac arrest, if patients are not able to respond to regular questionnaires (paper)
Telephonic interview for Cognitive Status
3 months after in-hospital cardiac arrest, if patients are not able to respond to regular questionnaires (paper)
CSI
大体时间:3 months and one year after in-hospital cardiac arrest
Caregiver strain index for caregivers of In-Hospital Cardiac Arrest Survivors
3 months and one year after in-hospital cardiac arrest

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Robert Jan Stolker, MD PhD、Erasmus Medical Center
  • 首席研究员:Marc Schluep, MD、Erasmus Medical Center
  • 学习椅:Sanne Hoeks, PhD、Erasmus Medical Center
  • 学习椅:Henrik Endeman, MD PhD、OLVG

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2017年1月1日

初级完成 (实际的)

2019年6月1日

研究完成 (实际的)

2019年7月1日

研究注册日期

首次提交

2017年4月6日

首先提交符合 QC 标准的

2017年4月18日

首次发布 (实际的)

2017年4月19日

研究记录更新

最后更新发布 (实际的)

2019年7月16日

上次提交的符合 QC 标准的更新

2019年7月14日

最后验证

2019年7月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • ABR55661.078.16
  • NTR6145 (其他标识符:Dutch Trial Registry)
  • MEC-2016-563 (其他标识符:Erasmus MC METC)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

生活质量的临床试验

订阅